Form 8-K - Current report:
SEC Accession No. 0001193125-25-000647
Filing Date
2025-01-02
Accepted
2025-01-02 16:13:52
Documents
13
Period of Report
2024-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d853375d8k.htm   iXBRL 8-K 26561
  Complete submission text file 0001193125-25-000647.txt   149423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtem-20241230.xsd EX-101.SCH 2840
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20241230_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20241230_pre.xml EX-101.PRE 11254
16 EXTRACTED XBRL INSTANCE DOCUMENT d853375d8k_htm.xml XML 3674
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 25502171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)